REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/28/2026
Back to search
Official data from USPTO
MERIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/01/2026
Trademark type
Word
Nice classes
1, 5, 44
Filing date
05/18/2015
Registration date
02/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
03/01/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
First use anywhere
06/25/1982
First use in commerce
06/25/1982
Drawing code
4
Owner type
03
Owner location
Los Angeles, CA, US
Examiner
KHAN, ASMAT A
Law office
M50
Holders and representatives
Holders
Merit Healthcare International, Inc.
Representatives
Matthew J. Clark Frost Brown Todd LLP
Technical classification
Nice Classes
Class 1Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Sterile non-pyrogenic distilled water used as a diluent for parenteral injection solutions
Class 5
Pharmaceuticals for the treatment of medical conditionsprescription pharmaceutical productsoral pharmaceuticalstopical pharmaceuticals for the treatment of infectious diseasesskin diseases and conditionsinternal diseases and conditions; Vaccines; Nutritional supplements; Pharmaceutical preparationsgeneral anestheticssedativesanti-infectivescardiovascular pharmaceuticalsanti-emeticsdiluents for use in reconstituting and diluting other pharmaceutical agents; Dietetic substancesvitaminslipidsamino acids for medical purposeselectrolytes; Full line of pharmaceutical preparations for intravenous administrationelectrolytessaline solution for medical purposesdextroseheparinlactated ringers; Anti-infective agents; Medical solutions for intermittent or continuous intravenous infusion for treatment of cardiovascular diseaseprevention or treatment of infections; Critical care premixed medicines for fluid replacement; Medicated skin ointment; Medical solutions for wound irrigation; Fluids for parenteral medical usemineralvitaminnutritionally enhanced water for injection for medical purposesdextrose in waterdextrose and sodium chloride in watersodium chloride in waterdextrose and vitamins in waterdextrosesodium chloridevitamins in waterdextrosealcoholsodium chloridevitamins in waterdextrosealcoholvitamins in watersodium chloridepotassium chloridecalcium chloride in waterdextrosesodium chloridepotassium chloridecalcium chloride in watersodium r-lactate in watersodium r-lactatesodium chloridepotassium chloridecalcium chloride in watersodium r-lactatesodium chloridepotassium chloridecalcium chloridedextrose in waterdextrosealcoholsodium chloride in waterhydrolyzed protein in watersodium sulfate in waterfor medical purposes; Solutions for parenteral medical usevarious concentrations of dextrose in watervarious concentrations of dextrose and sodium chloride in watervarious concentrations of sodium chloride in watervarious concentrations of vitamins in watervarious concentrations of dextrose with sodium chloride and vitamins in watervarious concentrations of dextrose and alcohol with sodium chloride and vitamins in watervarious concentrations of dextrose and alcohol with vitamins in watersodium chloridepotassium chloridecalcium chloride in watervarious concentrations of calcium chloride in watersodium r-lactatesodium chloridepotassium chloridecalcium chloride in watersodium r-lactate in watervarious concentrations of dextrose and alcohol with sodium chloride in watervarious concentrations of dextrose and alcohol in watervarious concentrations of magnesium sulfate in waterfor medical purposes; Medicated water for the treatment of infectious diseasesskin diseases and conditionsinternal diseases and conditions; Various concentrations of sodium citrate in watervarious concentrations of potassium chloridesodium chloridesodium lactate in watervarious concentrations of potassium chloride in watervarious concentrations of invert sugar in watervarious concentrations of invert sugar and sodium chloride in watersodium chloridepotassium chloridecalcium chloride with dextrose in water for medical purposes; Solutions for enteral usevarious concentrations of hydrolyzed protein with carbohydrates and minerals in water for medical purposes; Blood anticoagulant and preservative agentsheparin; Various concentrations of sodium citrate in water for medical purposesvarious concentrations of dextrosesodium citratesodium chloride in water for medical purposesvarious concentrations of citric acid in water for medical purposes
Class 44
Providing information relating to therapeutic properties of pharmaceuticals relating to the treatment of medical conditions to healthcare providers and patients
Publications
History of USPTO decisions and trademark events.
30 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/13/2024
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/13/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2024
E815
TEAS SECTION 8 & 15 RECEIVED
08/28/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/27/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/27/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
02/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/13/2016
PUBO
PUBLISHED FOR OPPOSITION
12/13/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/31/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2016
GNRT
NON-FINAL ACTION E-MAILED
04/28/2016
CNRT
NON-FINAL ACTION WRITTEN
04/28/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2015
GNRT
NON-FINAL ACTION E-MAILED
09/08/2015
CNRT
NON-FINAL ACTION WRITTEN
09/08/2015
DOCK
ASSIGNED TO EXAMINER
08/27/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/27/2015
Continuous trademark protection
Get notified about every new filing that threatens MERIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.